IL1A rs1800587 associates with chronic noncrisis pain in sickle cell disease

Pharmacogenomics

Volumn 17, Issue 18, 2016, Pages 1999-2006

  Hu, Xiaoyu ^a   Jhun, Ellie H ^a   Yao, Yingwei ^a,b   He, Ying ^a   Molokie, Robert E ^a,c,d   Wilkie, DIana J ^a,b   Wang, Zaijie J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF NURSING   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

chronic; inflammation; interleukin; pain; pain crisis; polymorphism; promoter; sickle cell; transcription

Indexed keywords

CYTOSINE; INTERLEUKIN 1ALPHA; THYMINE; IL1A PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IL1A GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PAIN ASSESSMENT; PAIN SEVERITY; PAINREPORTIT QUESTIONNAIRE; PHENOTYPE; QUESTIONNAIRE; SCORING SYSTEM; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION REGULATION; ADOLESCENT; AGED; GENETICS; MIDDLE AGED; NECROSIS;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; CHRONIC PAIN; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; MALE; MIDDLE AGED; NECROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85003005775     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs-2016-0085     Document Type: Article

References (46)

1. Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease. Rates and risk factors. N. Engl. J. Med. 325(1), 11-16 (1991).
2. Wilkie DJ, Molokie R, Boyd-Seal D et al. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J. Natl Med. Assoc. 102(1), 18-27 (2010).
3. Ingram VM. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178(4537), 792-794 (1956).
4. Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 303(13), 1288-1294 (2010).
5. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am. J. Hematol. 79(1), 17-25 (2005).
6. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 376(9757), 2018-2031 (2010).
7. Smith WR, Penberthy LT, Bovbjerg VE et al. Daily assessment of pain in adults with sickle cell disease. Ann. Intern. Med. 148(2), 94-101 (2008).
8. Vichinsky EP, Johnson R, Lubin BH. Multidisciplinary approach to pain management in sickle cell disease. Am. J. Pediatr. Hematol. Oncol. 4(3), 328-333 (1982).
9. Marsh S, King CR, Van Booven DJ, Revollo JY, Gilman RH, Mcleod HL. Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics 16(5), 441-448 (2015).
10. Small KM, Mcgraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43, 381-411 (2003).
11. Hocking LJ, Smith BH, Jones GT, Reid DM, Strachan DP, Macfarlane GJ. Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study. Pain 149(1), 143-151 (2010).
12. Bandeira IC, Rocha LB, Barbosa MC et al. Chronic inflammatory state in sickle cell anemia patients is associated with HBB()S haplotype. Cytokine 65(2), 217-221 (2014).
13. Sarray S, Mahdi N, Saleh LR, Almaoui WY. Reduction in serum IL-10 levels is a surrogate marker for predicting vasoocclusive crisis in sickle cell disease. Am. J. Hematol. 89(7), 789-790 (2014).
14. Keikhaei B, Mohseni AR, Norouzirad R et al. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. Eur. Cytokine. Netw. 24(1), 45-52 (2013).
15. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361(1-3), 184-187 (2004).
16. Wolf G, Livshits D, Beilin B, Yirmiya R, Shavit Y. Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice. Brain Behav. Immun. 22(7), 1072-1077 (2008).
17. Rodrigues DH, Leles BP, Costa VV et al. IL-1beta is involved with the generation of pain in experimental autoimmune encephalomyelitis. Mol. Neurobiol. 53(9), 6540-6547, 2016.
18. Del Rey A, Yau HJ, Randolf A et al. Chronic neuropathic pain-like behavior correlates with IL-1beta expression and disrupts cytokine interactions in the hippocampus. Pain 152(12), 2827-2835 (2011).
19. Lipworth BJ, Basu K, Donald HP et al. Tailored second-line therapy in asthmatic children with the Arg(16) genotype. Clin. Sci. (London) 124(8), 521-528 (2013).
20. Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 370(9605), 2118-2125 (2007).
21. Skoff AM, Zhao C, Adler JE. Interleukin-1alpha regulates substance P expression and release in adult sensory neurons. Exp. Neurol. 217(2), 395-400 (2009).
22. Kras JV, Dong L, Winkelstein BA. Increased interleukin-1alpha and prostaglandin E2 expression in the spinal cord at 1 day after painful facet joint injury: evidence of early spinal inflammation. Spine (Phila Pa 1976) 39(3), 207-212 (2014).
23. Zuurhout MJ, Vijverberg SJ, Raaijmakers JA et al. Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting beta2-agonists: results of the PACMAN cohort. Pharmacogenomics 14(16), 1965-1971 (2013).
24. Schistad EI, Jacobsen LM, Roe C, Gjerstad J. The interleukin-1alpha gene C>T polymorphism rs1800587 is associated with increased pain intensity and decreased pressure pain thresholds in patients with lumbar radicular pain. Clin. J. Pain 30(10), 869-874 (2014).
25. Solovieva S, Leino-Arjas P, Saarela J, Luoma K, Raininko R, Riihimaki H. Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain 109(1-2), 8-19 (2004).
26. Ezenwa MO, Molokie RE, Wang ZJ et al. Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease. J. Pain Symptom Manage. 48(1), 65-74 (2014).
27. Wilkie DJ, Molokie RE, Suarez ML, Ezenwa MO, Wang ZJ. Composite pain index: reliability, validity, and sensitivity of a patient-reported outcome for research. Pain Med. 16(7), 1341-1348 (2015).
28. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1, 277-299 (1975).
29. Ngamkham S, Holden JE, Wilkie DJ. Differences in pain location, intensity, and quality by pain pattern in outpatients with cancer. Cancer Nurs. 34(3), 228-237 (2011).
30. Wilkie DJ, Judge MK, Berry DL, Dell J, Zong S, Gilespie R. Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. J. Pain Symptom Manage. 25(3), 213-224 (2003).
31. Jhun E, He Y, Yao Y, Molokie RE, Wilkie DJ, Wang ZJ. Dopamine D3 receptor Ser9Gly and catechol-O methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease. Anesth. Analg. 119(5), 1201-1207 (2014).
32. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16(3), 1215 (1988).
33. Vandenbergh DJ, Anthony K, Whitfield KE. Optimizing DNA yield from buccal swabs in the elderly: attempts to promote buccal cell growth in culture. Am J. Hum. Biol. 15(5), 637-642 (2003).
34. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr. Protoc. Hum. Genet. Chapter 2, Unit 2, 12 (2009).
35. Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 31(4), 358-362 (2007).
36. Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT. Basic statistical analysis in genetic case-control studies. Nat. Protoc. 6(2), 121-133 (2011).
37. Cameron A, Trivedi PK. New York, NY. Regression Analysis of Count Data (1st Edition). Cambridge University Press (1998).
38. Negative Binomial Regression. SPSS Data Analysis Examples (23 November 2015). www.ats.ucla.edu/stat/spss/dae/neg-binom.htm
39. Kent WJ, Sugnet CW, Furey TS et al. The human genome browser at UCSC. Genome Res. 12(6), 996-1006 (2002).
40. Encyclopedia of DNA Elements at UCSC. https://genome.ucsc.edu/ENCODE/
41. Rosenbloom KR, Sloan CA, Malladi VS et al. ENCODE data in the UCSC genome browser: year 5 update. Nucleic Acids Res. 41(Database issue), D56-D63 (2013).
42. Thurman RE, Rynes E, Humbert R et al. The accessible chromatin landscape of the human genome. Nature 489(7414), 75-82 (2012).
43. Moen A, Schistad EI, Rygh LJ, Roe C, Gjerstad J. Role of IL1A rs1800587, IL1B rs1143627 and IL1RN rs2234677 genotype regarding development of chronic lumbar radicular pain; a prospective one-year study. PloS ONE 9(9), e107301 (2014).
44. Dominici R, Cattaneo M, Malferrari G et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54(2), 82-86 (2002).
45. Kohli DR, Li Y, Khasabov SG et al. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood 116(3), 456-465 (2010).
46. Mika J, Korostynski M, Kaminska D et al. Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 138(3), 587-597 (2008).